Related Experiment Video
Updated: May 21, 2025

09:42
Unraveling Entropic Rate Acceleration Induced by Solvent Dynamics in Membrane Enzymes
Published on: January 16, 2016
8.9K
Exploiting Solvent Exposed Salt-Bridge Interactions for the Discovery of Potent Inhibitors of SOS1 Using Free-Energy
Abba E Leffler1, Evelyne M Houang1, Felicia Gray2
1Schrödinger, Inc., New York, New York 10036, United States.
ACS Medicinal Chemistry Letters
|March 19, 2025
Summary
Researchers found that targeting specific acidic residues (E906, E909) on the Son of Sevenless 1 protein (SOS1) with basic molecules significantly enhances inhibitor binding. This discovery offers a new strategy for developing potent SOS1 inhibitors for cancer therapy.
Area of Science:
- Medicinal Chemistry
- Structural Biology
- Computational Chemistry
Background:
- Small molecules targeting Son of Sevenless 1 (SOS1) aim to inhibit RAS activation for antitumor effects.
- Existing SOS1 inhibitors face challenges in achieving high affinity and potency.
Purpose of the Study:
- To identify novel strategies for enhancing the affinity of small molecule SOS1 inhibitors.
- To explore the potential of targeting solvent-exposed acidic residues for improved drug design.
Main Methods:
- Free-energy perturbation (FEP+) simulations were employed to guide inhibitor design.
- Structure-Activity Relationship (SAR) studies were conducted to validate computational findings.
- X-ray crystallography was used to elucidate the binding interactions at the molecular level.
Main Results:
- Two acidic residues (E906, E909) on SOS1 were identified as a key 'potency handle'.
- Targeting these residues with basic groups resulted in up to a 750-fold increase in inhibitor affinity.
- Electrostatic interactions, specifically salt bridges, were confirmed as the mechanism for affinity enhancement.
Conclusions:
- The electrostatic interaction with solvent-exposed acidic residues represents a generalizable strategy for developing potent SOS1 inhibitors.
- This approach can be repurposed for broader drug discovery efforts targeting other protein classes.
- The findings provide a new avenue for the development of targeted cancer therapies.

